@article{3347889,
    title = "May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019",
    author = "Poulter, N.R. and Borghi, C. and Damasceno, A. and Jafar, T.H. and Khan, N.A. and Kokubo, Y. and Nilsson, P.M. and Prabhakaran, D. and Schlaich, M.P. and Schutte, A.E. and Stergiou, G.S. and Unger, T. and Wang, W. and Beaney, T.",
    journal = "European Heart Journal Supplements: Journal of the European Society of Cardiology",
    year = "2022",
    volume = "24",
    number = "Sf",
    pages = "F1-F5",
    publisher = "Oxford University Press",
    issn = "1520-765X, 1554-2815",
    doi = "10.1093/eurheartjsupp/suac045",
    keywords = "antihypertensive agent, alcohol consumption;  antihypertensive therapy;  Article;  blood pressure monitoring;  blood sampling;  body mass;  body weight;  cardiovascular risk factor;  clinical protocol;  finance;  information processing;  medical record;  methodology;  patient health questionnaire;  public health campaign;  screening;  urine sampling",
    abstract = "The frst May Measurement Month (MMM) campaign, a global blood pressure (BP) screening programme, began in 2017 as an initiative of the International Society of Hypertension.1 Two subsequent annual campaigns have also been completed in consecutive years2,3 and having had to defer activities due to the COVID-19 pandemic in 2020 the fourth campaign was run in 2021, the results of which are currently in press. Since its initiation in 2017, volunteers from more than 100 countries have participated. The aims of MMM have remained consistent from the start-to raise awareness of the importance of the measurement of BP at the individual and population level and to provide a temporary pragmatic solution to the shortfall in BP screening programmes in countries around the world. © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology."
}